IQVIA Holdings | IQV - Cash And Equivalent


IQVIA Holdings reported $1.95B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Accenture USD 10.17B 766.06M Mar/2026
Agilent USD 1.81B 49M Mar/2026
Bruker USD 133.4M 165.4M Mar/2026
Cardinal Health USD 3.94B 1.16B Mar/2026
Celltrion KRW 49.87B 20.22B Dec/2025
Charles River Laboratories USD 191.83M 21.94M Mar/2026
Cigna USD 7.04B 636M Mar/2026
Cognizant Technology Solutions USD 1.5B 397M Mar/2026
Computer Programs Systems USD 24.85M 4.93M Dec/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
CVS Health USD 9.54B 1.09B Mar/2026
Danaher USD 5.7B 1.09B Mar/2026
Dentsply International USD 190M 136M Mar/2026
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 627.67M 576.58M Mar/2026
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Elevance Health USD 9.66B 166M Mar/2026
Humana USD 4.95B 751M Mar/2026
IBM USD 10.82B 2.77B Mar/2026
Illumina USD 1.42B 368M Dec/2025
Infosys INR 3.59B 383M Sep/2025
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Laboratory Of America USD 981.1M 448.8M Mar/2026
Malin Corporation EUR 62.1M 26.4M Dec/2024
McKesson USD 3.98B 1.02B Mar/2026
Mettler Toledo International USD 66.89M 2.18M Dec/2025
Organigram Holdings CAD 4.29M 3.28M Mar/2026
Pharma Mar EUR 48.86M 31.05M Mar/2026
Publicis EUR 4.03B 1.83B Dec/2025
Qiagen NV USD 839M 516.58M Dec/2025
Quest Diagnostics USD 393M 27M Mar/2026
Revvity USD 860.32M 59.54M Mar/2026
Sartorius EUR 573.8M 32.4M Mar/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Tilray USD 264.83M 43.16M Jun/2025
UnitedHealth USD 31.23B 3.11B Mar/2026
Veeva Systems USD 1.9B 475.35M Mar/2026
Veradigm USD 492.6M 7.57M Sep/2022
Waters USD 462M 125.83M Mar/2026
Zealand Pharma A/S 4.58B 1.4B Dec/2025
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026